跳至主要内容
临床试验/EUCTR2016-000896-26-DK
EUCTR2016-000896-26-DK进行中(未招募)1 期

Effect of Tadalafil on cerebral large arteries in stroke patients. - Tadalafil and apoplexia.

Herlev Gentofte Hospital0 个研究点开始时间: 2016年3月10日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Radiological evidence of cerebral small vessel disease defined as: MRI evidence of lacunar infarct(s) (= 1.5 cm maximum diameter) and/or confluent deep white matter leukoaraiosis (= grade 2 on Fazekas scale).
  • 2.Clinical evidence of cerebral small vessel disease defined as:
  • a) lacunar stroke syndrome with symptoms lasting >24 hours, occurring at least 5 months previously;
  • b) transient ischaemic attack lasting < 24 hours with limb weakness, hemi-sensory loss or dysarthria at least 5 months previously AND with MR DWI performed acutely showing lacunar infarction, OR if MRI is not performed within 10 days of TIA, a lacunar infarction in an anatomically appropriate position is demonstrated on a subsequent MRI;
  • 3.Age = 50 years.
  • 4.Imaging of the carotid arteries with Doppler ultrasound, CT angiography or MR angiography in the previous 12 months, demonstrating < 70% stenosis in both internal carotid arteries.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • 1.Known diagnosis of dementia
  • 2. Pregnancy or nursing women
  • 3.Cortical infarction (>1.5 cm maximum diameter)
  • 4.Systolic BP < 90 and/or diastolic BP < 50
  • 5.eGFR < 30 ml/min/1,73 m2
  • 6.Severe hepatic impairment
  • 7.History of Lactose intolerance
  • 8.Concomitant use of PDE5 inhibitors e.g. sildenafil, tadalafil, vardenafil
  • 9.Patients receiving nicorandil and nitrates e.g. isosorbide mononitrate, isosorbide dinitrate, glyceryl trinitrate
  • 10.Body weight > 130kg
  • 11.Uncontrolled cardiac failure
  • 12.Persistent or paroxysmal atrial fibrillation
  • 13.History of ‘sick sinus syndrome’ or other supraventricular cardiac conduction conditions such as sinoatrial or atrioventricular block
  • 14.Uncontrolled COPD
  • 15.Stroke or TIA within the last 5 months.
  • 16.MRI not tolerated or contra-indicated : MRI exclusion criteria -Participant has a cardiac pacemaker; recent surgery; vascular clips; metal implants or joint replacements that are not compatible with MRI; have had metal fragments in their eyes; has ever worked on a lathe; has shrapnel from a war injury; possibility of pregnancy
  • 17.Known monogenic causes of stroke i.e. CADASIL
  • 18. The patient does not wish to know important results from MRI
  • 19.Unable to provide informed consent
  • 20. Not possible to localise a. cerebri media bilaterally on inclusion day with Transcranial Doppler.

研究者

发起方
Herlev Gentofte Hospital

相似试验